Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer von Forde, Patrick M., Spicer, Jonathan, Lu, Shun, Provencio, Mariano, Mitsudomi, Tetsuya, Awad, Mark M., Felip, Enriqueta, Broderick, Stephen R., Brahmer, Julie R., Swanson, Scott J., Kerr, Keith, Wang, Changli, Ciuleanu, Tudor-Eliade, Saylors, Gene B., Tanaka, Fumihiro, Ito, Hiroyuki, Chen, Ke-Neng, Liberman, Moishe, Vokes, Everett E., Taube, Janis M., Dorange, Cecile, Cai, Junliang, Fiore, Joseph, Jarkowski, Anthony, Balli, David, Sausen, Mark, Pandya, Dimple, Calvet, Christophe Y., Girard, Nicolas

Volltext

Independence Number and Maximal Chromatic Polynomials of Connected Graphs von Long, Shude, Cai, Junliang

Volltext

Association between pathologic response and survival after neoadjuvant therapy in lung cancer von Deutsch, Julie Stein, Cimino-Mathews, Ashley, Thompson, Elizabeth, Provencio, Mariano, Forde, Patrick M., Spicer, Jonathan, Girard, Nicolas, Wang, Daphne, Anders, Robert A., Gabrielson, Edward, Illei, Peter, Jedrych, Jaroslaw, Danilova, Ludmila, Sunshine, Joel, Kerr, Keith M., Tran, Mia, Bushong, Judith, Cai, Junliang, Devas, Vipul, Neely, Jaclyn, Balli, David, Cottrell, Tricia R., Baras, Alex S., Taube, Janis M.

Volltext

The Crossing Number of Hexagonal Graph H3,n in the Projective Plane von Wang, Jing, Cai, Junliang, Lv, Shengxiang, Huang, Yuanqiu

Volltext

Abstract CT003: Nivolumab (NIVO) + platinum-doublet chemotherapy (chemo) vs chemo as neoadjuvant treatment (tx) for resectable (IB-IIIA) non-small cell lung cancer (NSCLC) in the p... von Forde, Patrick M., Spicer, Jonathan, Lu, Shun, Provencio, Mariano, Mitsudomi, Tetsuya, Awad, Mark M., Felip, Enriqueta, Broderick, Stephen, Brahmer, Julie, Swanson, Scott J., Kerr, Keith, Wang, Changli, Saylors, Gene B., Tanaka, Fumihiro, Ito, Hiroyuki, Chen, Ke-Neng, Dorange, Cecile, Cai, Junliang, Fiore, Joseph, Girard, Nicholas

Volltext

Characterizing tumor shrinkage as a measure of clinical benefit for immune checkpoint inhibitors von Kelleher, Thomas, Cai, Junliang, Botwood, Nicholas AJ, Labriola, Dominic F

Volltext

222-N Analysis of pathologic features and efficacy outcomes with neoadjuvant nivolumab plus platinum-doublet chemotherapy for resectable non-small cell lung cancer in CheckMate 816... von Deutsch, Julie Stein, Cimino-Mathews, Ashley, Thompson, Elizabeth, Provencio, Mariano, Forde, Patrick M, Spicer, Jonathan, Girard, Nicolas, Wang, Daphne, Anders, Robert A, Gabrielson, Edward, Illei, Peter, Jedrych, Jaroslaw, Danilova, Ludmila, Sunshine, Joel, Kerr, Keith M, Tran, Mia, Bushong, Judy, Cai, Junliang, Devas, Vipul, Neely, Jaclyn, Balli, David, Cottrell, Tricia R, Baras, Alex S, Taube, Janis

Volltext

Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer von Forde, Patrick M., Spicer, Jonathan, Lu, Shun, Provencio, Mariano, Mitsudomi, Tetsuya, Awad, Mark M., Felip, Enriqueta, Broderick, Stephen R., Brahmer, Julie R., Swanson, Scott J., Kerr, Keith, Wang, Changli, Ciuleanu, Tudor-Eliade, Saylors, Gene B., Tanaka, Fumihiro, Ito, Hiroyuki, Chen, Ke-Neng, Liberman, Moishe, Vokes, Everett E., Taube, Janis M., Dorange, Cecile, Cai, Junliang, Fiore, Joseph, Jarkowski, Anthony, Balli, David, Sausen, Mark, Pandya, Dimple, Calvet, Christophe Y., Girard, Nicolas

Volltext

Coefficients of the Chromatic Polynomials of Connected Graphs von Long, Shude, Cai, Junliang

Volltext

Counting rooted nearly cubic planar maps von Cai, Junliang, Zhan, Fuqin

Volltext

Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial von Wu, Yi-Long, Lu, Shun, Cheng, Ying, Zhou, Caicun, Wang, Jie, Mok, Tony, Zhang, Li, Tu, Hai-Yan, Wu, Lin, Feng, Jifeng, Zhang, Yiping, Luft, Alexander Valerievich, Zhou, Jianying, Ma, Zhiyong, Lu, You, Hu, Chengping, Shi, Yuankai, Baudelet, Christine, Cai, Junliang, Chang, Jianhua

Volltext

Model‐Based Population Pharmacokinetic Analysis of Nivolumab in Chinese Patients With Previously Treated Advanced Solid Tumors, Including Non–Small Cell Lung Cancer von Zhang, Jason, Cai, Junliang, Bello, Akintunde, Roy, Amit, Sheng, Jennifer

Volltext

The Number of Rooted Nearly 2-Regular Loopless Planar Maps von Long, Shude, Cai, Junliang

Volltext

Unicyclic and bicyclic graphs with minimal augmented Zagreb index von Zhan, Fuqin, Qiao, Youfu, Cai, Junliang

Volltext

Neoadjuvant nivolumab plus chemotherapy in resectable non‐small‐cell lung cancer in Japanese patients from CheckMate 816 von Mitsudomi, Tetsuya, Ito, Hiroyuki, Okada, Morihito, Sugawara, Shunichi, Shio, Yutaka, Tomii, Keisuke, Okami, Jiro, Sakakura, Noriaki, Kubota, Kaoru, Takamochi, Kazuya, Atagi, Shinji, Tsuboi, Masahiro, Oizumi, Satoshi, Ikeda, Norihiko, Ohde, Yasuhisa, Ntambwe, Ives, Mahmood, Javed, Cai, Junliang, Tanaka, Fumihiro

Volltext

CheckMate 73L: A Phase 3 Study Comparing Nivolumab Plus Concurrent Chemoradiotherapy Followed by Nivolumab With or Without Ipilimumab Versus Concurrent Chemoradiotherapy Followed b... von De Ruysscher, Dirk, Ramalingam, Suresh, Urbanic, James, Gerber, David E, Tan, Daniel S.W., Cai, Junliang, Li, Ang, Peters, Solange

Volltext

60 - Event-free survival (EFS) with neoadjuvant nivolumab (NIVO) + platinum-doublet chemotherapy (chemo) versus chemo by surgical outcomes in resectable non-small cell lung cancer... von Spicer, Jonathan, Wang, Changli, Tanaka, Fumihiro, Chen, Ke-Neng, Ito, Hiroyuki, Liberman, Moishe, Chen, Qixun, Girard, Nicolas, Lu, Shun, Provencio, Mariano, Mitsudomi, Tetsuya, Awad, Mark, Felip, Enriqueta, Swanson, Scott, Forde, Patrick, Cai, Junliang, Mahmood, Javed, Hu, Nan, Tran, Phuong, Broderick, Stephen

Volltext

Event-free survival (EFS) with neoadjuvant nivolumab (NIVO) + platinum-doublet chemotherapy (chemo) versus chemo by surgical outcomes in resectable non-small cell lung cancer (NSCL... von Spicer, Jonathan, Wang, Changli, Tanaka, Fumihiro, Chen, Ke-Neng, Ito, Hiroyuki, Liberman, Moishe, Chen, Qixun, Girard, Nicolas, Lu, Shun, Provencio, Mariano, Mitsudomi, Tetsuya, Awad, Mark, Felip, Enriqueta, Swanson, Scott, Forde, Patrick, Cai, Junliang, Mahmood, Javed, Hu, Nan, Tran, Phuong, Broderick, Stephen

Volltext

Clinical outcomes with neoadjuvant nivolumab (N) + chemotherapy (C) vs C by definitive surgery in patients (pts) with resectable NSCLC: 3-y results from the phase 3 CheckMate 816 t... von Spicer, Jonathan, Forde, Patrick M., Provencio, Mariano, Lu, Shun, Wang, Changli, Mitsudomi, Tetsuya, Broderick, Stephen, Swanson, Scott, Awad, Mark M., Felip, Enriqueta, Brahmer, Julie R., Kerr, Keith, Saylors, Gene Brian, Chen, Ke-Neng, Tanaka, Fumihiro, Cai, Junliang, Mahmood, Javed, Hu, Nan, Tran, Phuong, Girard, Nicolas

Volltext

Neoadjuvant nivolumab (NIVO) + platinum-doublet chemotherapy (chemo) versus chemo for resectable (IB–IIIA) non-small cell lung cancer (NSCLC): Association of pathological regressio... von Provencio-Pulla, Mariano, Spicer, Jonathan, Taube, Janis M., Martin, Claudio, Spigel, David R., Wang, Changli, Girard, Nicolas, Lu, Shun, Mitsudomi, Tetsuya, Awad, Mark M., Felip, Enriqueta, Brahmer, Julie R., Broderick, Stephen, Swanson, Scott, Kerr, Keith, Li, Li, Cai, Junliang, Bushong, Judith, Tran, Phuong, Forde, Patrick M.

Volltext